abstract Objective: The aim was to formulate practice guidelines for the diagnosis and
treatment of hyperprolactinemia. Participants: The Task Force consisted of Endocrine …

Prolactinomas account for approximately 40% of all pituitary adenomas and are an
important cause of hypogonadism and infertility. The ultimate goal of therapy for …

Prolactinomas are the most common pituitary adenomas (approximately 40% of cases), and
they represent an important cause of hypogonadism and infertility in both sexes. The …

A 42-year-old man presents with decreased libido, erectile dysfunction, and headaches. He
reports no weight change, gynecomastia, fatigue, or other symptoms. He takes no …

Hyperprolactinemia is one of the most frequently diagnosed clinical disorders in routine
endocrine practice. Any process interfering with dopamine synthesis, its transport to the …

Context: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic
idiopathic hyperprolactinemia. However, the optimal treatment strategy and treatment …

This review focusses on the epidemiology, diagnosis and treatment of prolactinomas. In
particular, attention was given to recent data showing a high prevalence of these tumours in …

Prolactinomas, the most prevalent type of neuroendocrine disease, account for
approximately 40% of all pituitary adenomas. The most important clinical problems …

Objective Medical therapy with dopamine agonists (DA) is the primary treatment of choice in
most patients with prolactinomas.'Classical'surgical indications are intolerance or lack of …

Background Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …